Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ANAB
#1840
AnaptysBio, Inc. Common Stock
55.050
0
+1.79%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
+1.79%
Monatliche Änderung
+11.53%
6 month change
+56.39%
Jahresänderung
+56.39%
Vorheriger Schlusskurs
54.080
0
Open
55.050
0
Bid
Ask
Low
55.050
0
High
55.146
0
Volumen
74
Märkte
Aktien
Gesundheitswesen
ANAB
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
30.43 M
30.67 M
29.38 M
28 M
27.69 M
—
Valuation ratios
Enterprise value
827.78 M
282.95 M
447.55 M
577.23 M
737.99 M
2.05 B
Price to earnings ratio
-5.51
-2.59
-3.91
-5.06
-11.22
-22.76
Price to sales ratio
16.02
4.12
4.75
5.21
5.28
19.36
Price to cash flow ratio
-8.78
-2.78
-4.83
-5.03
-6.13
-18.76
Price to book ratio
3.96
5.3
2.65
4.31
28.07
40.34
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.07
0.05
0.09
0.12
0.04
0.3
Return on equity %
0.39
0.31
1.16
0.86
0.51
2.84
Return on invested capital %
167.79
76.13
190.36
197.25
244.78
708.52
Gross margin %
100
100
100
100
100
400
Operating margin %
75.81
22.43
99.16
117.55
45.47
284.62
EBITDA margin %
—
—
—
—
—
—
Net margin %
109.44
50.53
141.62
173.52
19.8
385.47
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
10.23
9.51
8.25
8.22
8.68
34.65
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.07
0.09
0.06
0.06
0.22
0.43
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.35
2.35
0.35
1.4
0.94
5.04
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
14.89
13.58
11.09
9.22
8.58
42.47
Net current asset value per share
15.53
15.22
11.85
10.13
11.39
48.59
Tangible book value per share
2.92
2.5
1.11
1.55
1.01
6.17
Working capital per share
14.01
13.62
10.41
8.9
10.08
43.01
Book value per share
2.92
2.5
1.11
1.55
1.01
6.17
Nachrichten
La FDA acepta la solicitud de imsidolimab de Vanda para trastorno cutáneo raro
FDA accepts Vanda’s imsidolimab application for rare skin disorder
La acción de AnaptysBio alcanza un máximo de 52 semanas en 57,73 dólares
Acción de AnaptysBio alcanza un máximo de 52 semanas en $57.73
AnaptysBio stock hits 52-week high at $57.73
These IBD 50 Stocks Form Secondary Buy Areas, But Watch These Risks
Acciones de AnaptysBio alcanzan un máximo de 52 semanas a $52.56
Las acciones de AnaptysBio alcanzan un máximo de 52 semanas a 52,56 dólares
AnaptysBio stock hits 52-week high at $52.56
Biotech Leader Eyes Spinoff Amid Massive Sales Surge
AnaptysBio, Inc. (ANAB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Acciones de AnaptysBio: UBS reitera calificación de Compra en medio de litigio con GSK